Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.

[1]  D. Yadav,et al.  The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent , 2020, Alimentary pharmacology & therapeutics.

[2]  S. Choi,et al.  Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  M. Falconi,et al.  Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer , 2020, Cancers.

[4]  A. Dabrowski,et al.  Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club , 2019, Przeglad gastroenterologiczny.

[5]  M. Strother,et al.  The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study , 2019, Palliative care.

[6]  Prashanth Rawla,et al.  Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors , 2019, World journal of oncology.

[7]  J. Neoptolemos,et al.  Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[8]  K. Koike,et al.  A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer , 2018, Pancreas.

[9]  J. Iglesias-Garcia,et al.  Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis , 2018, BMC Cancer.

[10]  J. Hodson,et al.  Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[11]  N. Massarweh,et al.  Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection , 2017, Nutrients.

[12]  Steven D. Freedman,et al.  Practical guide to exocrine pancreatic insufficiency – Breaking the myths , 2017, BMC Medicine.

[13]  C. Oldmeadow,et al.  Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC) , 2017, Supportive Care in Cancer.

[14]  Jason R. Rodgers,et al.  Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis , 2016, Gut.

[15]  J. Neoptolemos,et al.  Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery , 2016, Annals of surgery.

[16]  Seung Hyun Chung,et al.  Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[17]  W. Wassef,et al.  Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[18]  I. B. Borel Rinkes,et al.  Pancreatic Exocrine Insufficiency in Patients With Pancreatic or Periampullary Cancer: A Systematic Review , 2016, Pancreas.

[19]  A. Andriulli,et al.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. , 2013, World journal of gastroenterology.

[20]  K. Lillemoe,et al.  Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. , 2010, Archives of surgery.

[21]  L. Traverso,et al.  Pancreatic Exocrine Function Is Preserved After Distal Pancreatectomy , 2010, Journal of Gastrointestinal Surgery.

[22]  P. Maisonneuve,et al.  Low Fecal Elastase 1 Levels Do Not Indicate Exocrine Pancreatic Insufficiency in Type-1 Diabetes Mellitus , 2008, Pancreas.

[23]  C. Forsmark,et al.  Pancreatic function testing , 2003, Alimentary pharmacology & therapeutics.

[24]  G. Tytgat,et al.  Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region , 1998, Gut.

[25]  U. Fölsch,et al.  Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. , 1996, Gut.

[26]  H. Schrem,et al.  Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[27]  R. Micciolo,et al.  Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[28]  R. Laugier,et al.  Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  B. Lembcke,et al.  Functional reserve capacity of the exocrine pancreas. , 1986, Digestion.